Atorvastatin,134523-01-6

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Atorvastatin sodium

CAS No. : 134523-01-6

MCE 国际站：Atorvastatin sodium

产品活性：Atorvastatin sodium 是一种具有口服活性的 HMG-CoA 还原酶抑制剂，具有有效降低血脂的能力。Atorvastatin sodium 以 IC₅₀ 值分别为 0.39 μM 和 2.39 μM 来抑制人 SV-SMC 细胞的增殖和侵袭。

研究领域：Metabolic Enzyme/Protease  |  Autophagy

作用靶点：HMG-CoA Reductase (HMGCR)  |  Autophagy

In Vitro: Atorvastatin sodium decreases apoptosis of myocardial cells by down-regulating GRP78, caspase-12 and CHOP expression in myocardial cells after myocardial infarction, and the endoplasmic reticulum (ER) stress is activated in response to heart failure and angiotensin II (Ang II) stimulation.

In Vivo: Atorvastatin (20-30 mg/kg; oral gavage; once a day; for 28 days; ApoE^−/− mice) sodium significantly reduces endoplasmic reticulum (ER) stress signaling proteins, the number of apoptotic cells, and the activation of Caspase12 and Bax in the Ang II-induced ApoE-/- mice. Proinflammatory cytokines such as IL-6, IL-8, IL-1β are all remarkably inhibited after Atorvastatin sodium treatment.

相关产品：Simvastatin  |  Lovastatin  |  Atorvastatin hemicalcium salt  |  Rosuvastatin Calcium  |  Mevastatin  |  Pitavastatin Calcium  |  Fluvastatin sodium  |  Pravastatin sodium  |  Cerivastatin sodium  |  SR12813  |  Simvastatin acid ammonium  |  Meglutol  |  Hesperetin 7-O-glucoside  |  Lovastatin hydroxy acid sodium  |  Atorvastatin lactone  |  Clinofibrate  |  Pitavastatin-d4 sodium  |  Atorvastatin-d5 hemicalcium  |  (3R,5S)-Fluvastatin sodium  |  HMG499  |  Monacolin J  |  Pitavastatin-d5 sodium

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds